Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients - Discussion

被引:0
|
作者
Lund, DP
McKee, M
机构
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:975 / 975
页数:1
相关论文
共 50 条
  • [1] Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients
    McKee, M
    Mattei, P
    Schwarz, K
    Wise, B
    Colombani, P
    JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (07) : 973 - 975
  • [2] Neurotoxicity in pediatric renal transplant recipients treated with FK506 (tacrolimus).
    Neu, AM
    Furth, SL
    Case, BW
    Wise, B
    Colombani, PM
    Fivush, BA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 2177 - 2177
  • [3] Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506)
    Neu, AM
    Furth, SL
    Case, BW
    Wise, B
    Colombani, PM
    Fivush, BA
    CLINICAL TRANSPLANTATION, 1997, 11 (05) : 412 - 414
  • [4] CyA to tacrolimus (FK506) conversion in liver transplant recipients
    Cuomo, O
    Iovine, L
    Carfora, T
    De Luca, M
    Di Palma, M
    Anello, R
    LIVER TRANSPLANTATION, 2004, 10 (06) : C39 - C39
  • [5] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    Wallemacq, PE
    Furlan, V
    Möller, A
    Schäfer, A
    Stadler, P
    Firdaous, I
    Taburet, AM
    Reding, R
    De Clety, SC
    De Goyet, JD
    Sokal, E
    Lykavieris, L
    Van Leeuw, V
    Bernard, O
    Otte, JB
    Undre, NA
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (03) : 367 - 370
  • [6] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    P. E. Wallemacq
    V. Furlan
    A. Möller
    A. Schäfer
    P. Stadler
    I. Firdaous
    A -M. Taburet
    R. Reding
    S. Clement De Clety
    J. De Ville De Goyet
    E. Sokal
    L. Lykavieris
    V. Van Leeuw
    O. Bernard
    J. B. Otte
    N. A. Undre
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 367 - 370
  • [7] THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    MCDIARMID, SV
    WALLACE, P
    VARGAS, J
    AMENT, ME
    BUSUTTIL, RW
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 20 (03): : 291 - 299
  • [8] Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients
    McKee, M
    Segev, D
    Wise, B
    Case, B
    Neu, A
    Fivush, B
    Colombani, P
    JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (05) : 688 - 690
  • [9] Population pharmacokinetic study of tacrolimus (FK506) in adult liver transplant recipients.
    Zahir, H
    Nelson, A
    Gleeson, M
    McCaughan, G
    McLachlan, AJ
    Akhlaghi, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 365 - 365
  • [10] Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy
    Cacciarelli, TV
    Green, M
    Jaffe, R
    Mazariegos, GV
    Jain, A
    Fung, JJ
    Reyes, J
    TRANSPLANTATION, 1998, 66 (08) : 1047 - 1052